US2025367357A1PendingUtilityA1
Resin, adsorption material, and method of lowering ldl-c concentration in blood
Est. expiryMay 30, 2044(~17.8 yrs left)· nominal 20-yr term from priority
A61M 2202/08A61M 1/3679C08G 75/23C07D 303/22C07D 303/16C08L 71/00C09J 181/06C09D 181/06C08L 81/06C08G 65/4056
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A resin is formed through a ring-opening reaction of dextran sulfate sodium salt and a modified polyether sulfone. The modified polyether sulfone is formed by a reaction of polyether sulfone and an epoxy compound containing a carbon-carbon double bond. The resin may serve as an adsorption material, which can be a porous film or a porous hollow fiber. The adsorption material can be in contact with blood to lower LDL-C concentration in the blood.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A resin, formed through a ring-opening reaction of dextran sulfate sodium salt and a modified polyether sulfone,
wherein the modified polyether sulfone is formed by a reaction of polyether sulfone and an epoxy compound containing a carbon-carbon double bond.
2 . The resin as claimed in claim 1 , wherein the polyether sulfone and the epoxy compound containing a carbon-carbon double bond have a weight ratio of 100:20 to 100:30.
3 . The resin as claimed in claim 1 , wherein the modified polyether sulfone and the dextran sulfate sodium salt have a weight ratio of 100:1 to 100:1500.
4 . The resin as claimed in claim 1 , wherein a repeating unit of the polyether sulfone is
or a combination thereof.
5 . The resin as claimed in claim 1 , wherein the polyether sulfone has a weight average molecular weight of 55,000 g/mol to 75,000 g/mol.
6 . The resin as claimed in claim 1 , wherein the dextran sulfate sodium salt has a weight average molecular weight of 5000 g/mol to 10000 g/mol.
7 . The resin as claimed in claim 1 , wherein the epoxy compound containing a carbon-carbon double bond is
or a combination thereof.
8 . An adsorption material, comprising the resin as claimed in claim 1 ,
wherein the adsorption material is in a form of a porous film or a porous hollow fiber.
9 . The adsorption material as claimed in claim 8 , wherein the adsorption material has a porosity of 60% to 90%.
10 . The adsorption material as claimed in claim 8 , wherein the porous film has a thickness of 20 micrometers to 60 micrometers.
11 . The adsorption material as claimed in claim 8 , wherein the porous hollow fiber has an inner diameter of 300 micrometers to 600 micrometers, and the porous hollow fiber has a thickness of 80 micrometers to 150 micrometers.
12 . A method of lowering low-density lipoprotein cholesterol concentration in blood, comprising:
bringing blood into contact with the adsorption material as claimed in claim 8 to lower low-density lipoprotein cholesterol concentration in the blood.Join the waitlist — get patent alerts
Track US2025367357A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.